RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

In fact, according to the Centers for Disease Control and Prevention, the virus is the leading cause of infant hospitalization. Infants with RSV infection almost always show symptoms, which tend ...

The seasonal COVID-19 spike, combined with rising cases of seasonal flu and RSV, brings what has been called a “tripledemic.” ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Getting the annual RSV shot and other important vaccines is a fantastic way to safeguard yourself and your family as winter ...

Approval was based on results from the phase III ConquerRSV trial, which demonstrated a vaccine efficacy of 83.7% in ...

The holidays are fast approaching along with cooler weather and various respiratory illnesses. Here's when to get your ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Australia will fund free RSV vaccines for newborns and pregnant women starting in 2025, aiming to protect vulnerable groups ...

Pediatric RSV off-season outbreaks and positivity rates increased in China during the COVID-19 pandemic, according to study findings.

which demonstrated a vaccine efficacy of 83.7% in preventing RSV-associated lower respiratory tract disease with at least two signs or symptoms and an efficacy of 82.4% against lower respiratory ...